Suppr超能文献

CDD-1酶与阿维巴坦的时间分辨相互作用为D类β-内酰胺酶的催化机制提供了新见解。

Time-Resolved Interaction of the CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D β-lactamases.

作者信息

Stewart Nichole K, Toth Marta, Stasyuk Anastasiya, Vakulenko Sergei B, Smith Clyde A

机构信息

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, United States.

Stanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California 94025, United States.

出版信息

ACS Infect Dis. 2021 Jun 11;7(6):1765-1776. doi: 10.1021/acsinfecdis.1c00094. Epub 2021 Apr 28.

Abstract

Class D β-lactamases have risen to notoriety due to their wide spread in bacterial pathogens, propensity to inactivate clinically important β-lactam antibiotics, and ability to withstand inhibition by the majority of classical β-lactamase inhibitors. Understanding the catalytic mechanism of these enzymes is thus vitally important for the development of novel antibiotics and inhibitors active against infections caused by antibiotic-resistant bacteria. Here we report an time-resolved study of the interaction of the class D β-lactamase CDD-1 from with the diazobicyclooctane inhibitor, avibactam. We show that the catalytic carboxylated lysine, a residue that is essential for both acylation and deacylation of β-lactams, is sequestered within an internal sealed pocket of the enzyme. Time-resolved snapshots generated in this study allowed us to observe decarboxylation of the lysine and movement of CO and water molecules through a transient channel formed between the lysine pocket and the substrate binding site facilitated by rotation of the side chain of a conserved leucine residue. These studies provide novel insights on avibactam binding to CDD-1 and into the catalytic mechanism of class D β-lactamases in general.

摘要

D类β-内酰胺酶因在细菌病原体中广泛传播、有使临床上重要的β-内酰胺抗生素失活的倾向以及能耐受大多数经典β-内酰胺酶抑制剂的抑制作用而声名狼藉。因此,了解这些酶的催化机制对于开发新型抗生素和对抗由耐药菌引起的感染的抑制剂至关重要。在此,我们报告了一项关于来自[具体来源未提及]的D类β-内酰胺酶CDD-1与二氮杂双环辛烷抑制剂阿维巴坦相互作用的时间分辨研究。我们发现,催化性的羧化赖氨酸(β-内酰胺酰化和去酰化所必需的残基)被隔离在酶的一个内部封闭口袋中。本研究中生成的时间分辨快照使我们能够观察到赖氨酸的脱羧以及CO和水分子通过由一个保守亮氨酸残基侧链旋转促进在赖氨酸口袋和底物结合位点之间形成的瞬态通道的移动。这些研究为阿维巴坦与CDD-1的结合以及一般D类β-内酰胺酶的催化机制提供了新的见解。

相似文献

2
Inhibition of the Class D β-Lactamase CDD-1 by Avibactam.阿维巴坦对 Class D β-内酰胺酶 CDD-1 的抑制作用。
ACS Infect Dis. 2021 May 14;7(5):1164-1176. doi: 10.1021/acsinfecdis.0c00714. Epub 2021 Jan 3.
7
Avibactam and inhibitor-resistant SHV β-lactamases.阿维巴坦与耐抑制剂的SHVβ-内酰胺酶
Antimicrob Agents Chemother. 2015 Jul;59(7):3700-9. doi: 10.1128/AAC.04405-14. Epub 2015 Feb 17.
8
Class D β-lactamases: a reappraisal after five decades.D 类 β-内酰胺酶:五十年后的再评价。
Acc Chem Res. 2013 Nov 19;46(11):2407-15. doi: 10.1021/ar300327a. Epub 2013 Jul 31.

引用本文的文献

3
Drug Discovery in the Field of β-Lactams: An Academic Perspective.β-内酰胺类药物研发:学术视角
Antibiotics (Basel). 2024 Jan 8;13(1):59. doi: 10.3390/antibiotics13010059.

本文引用的文献

1
Inhibition of the Class D β-Lactamase CDD-1 by Avibactam.阿维巴坦对 Class D β-内酰胺酶 CDD-1 的抑制作用。
ACS Infect Dis. 2021 May 14;7(5):1164-1176. doi: 10.1021/acsinfecdis.0c00714. Epub 2021 Jan 3.
3
Recent advances in the development of β-lactamase inhibitors.β-内酰胺酶抑制剂的最新研究进展。
J Microbiol. 2020 Aug;58(8):633-647. doi: 10.1007/s12275-020-0285-z. Epub 2020 Jul 27.
6
A surface loop modulates activity of the Bacillus class D β-lactamases.表面环调节芽孢杆菌 D 类β-内酰胺酶的活性。
J Struct Biol. 2020 Aug 1;211(2):107544. doi: 10.1016/j.jsb.2020.107544. Epub 2020 Jun 5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验